Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Subscribe To Our Newsletter & Stay Updated
